The current guideline represents the 6th edition of the “Japanese Clinical Practice Guideline
for Diabetes” which has been revised every three years since its first appearance in 2004 to …

The global prevalence of diabetes has risen in adults from 4.7% in 1980 to 8.5% in 2014. 90–
95% of adults with diabetes have Type 2 diabetes (T2D). This paper focuses on the …

Aims To provide up-to-date estimates of undiagnosed diabetes mellitus (UDM) prevalence-
both globally, and by region/country, for the year 2021. Methods Data sources reporting …

Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …

Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …

Background Traditional risk factors are insufficient to explain all cases of coronary artery
disease (CAD) in patients with diabetes mellitus (DM). Advanced glycation end-products …

Considering the lack of a comprehensive, multi-faceted overview of the ketogenic diet (KD)
in relation to health issues, we compiled the evidence related to the use of the ketogenic diet …

Since its inception in 2004, the “Clinical Practice Guidelines for the Treatment of Diabetes”
has attempted to promote evidence-based, rational, efficient and standardized clinical …

Introduction Electronic cigarettes (e-cigarettes) are promoted as a less risky alternative to
conventional cigarettes and have grown in popularity. Experimental and clinical evidence …

Cardiovascular disease is a major cause of morbidity and mortality in patients with type 2
diabetes mellitus, with a two-to fourfold increase in cardiovascular disease risk compared …